SAN JOSE, Calif., March 19 /PRNewswire-FirstCall/ -- VNUS Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the Sidoti & Company 13th Annual Emerging Growth Institutional Investor Forum, to be held March 24 - 25, 2009, at The Grand Hyatt Hotel in New York City. The management speaker will be Peter Osborne, Chief Financial Officer and Vice President of Finance and Administration.

VNUS' presentation is currently scheduled for 11:00 a.m. ET on Tuesday, March 24. The event will not be webcast.

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux, a progressive condition caused by incompetent vein valves in the leg. VNUS sells the Closure system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to treat diseased veins through the application of temperature-controlled RF energy. For more information, please visit the corporate website at www.vnus.com.

SOURCE VNUS Medical Technologies, Inc.